Auditory Repair Mechanisms by Using Mesenchymal Stem Cell and Pluripotent Stem Cell Induction: A Promising Novel Target: Review Article
Journal of Otorhinolaryngology and Facial Plastic Surgery,
Vol. 10 No. 1 (2024),
13 Esfand 2024
https://doi.org/10.22037/orlfps.v10i1.47427
Abstract
Background: Sensorineural hearing loss is a prevalent condition that affects many and results from damage to cochlear hair cells and spiral ganglion neurons. Current treatments offer partial auditory restoration but fail to address the underlying cellular damage. Cell-based therapies have emerged as a potential strategy for regenerating damaged auditory structures.
Aim: This review examines the recent progress and ongoing challenges in the application of cell therapy for hearing loss.
Methods: A comprehensive review of the literature was conducted searching through PubMed, Scopus, and Google Scholar with a focus on publications between 2000 and 2023. Studies were included if they addressed the use of stem cell-based therapies in hearing loss, involving both preclinical models and human trials. Data were collected on the used cell types, mechanisms of action, outcomes, and barriers to clinical application.
Results: ESCs, iPSCs, MSCs, and NPCs have been explored for hearing loss therapy. ESCs and iPSCs demonstrated the ability to differentiate into auditory hair cells and SGNs, showing potential for direct auditory repair. While preclinical studies in animal models showed partial restoration of auditory function, challenges such as limited cell survival, maturation, and integration persist. Initial clinical trials using MSCs have demonstrated safety, with mild improvements in hearing function, though significant functional recovery is not yet definitive.
Conclusion: Cell therapy offers a novel approach for treating SNHL, but further research is necessary to optimize cell survival, delivery, and integration. Future clinical trials and advancements in stem cell technology will be critical to translating these findings into viable treatments.
- Hearing loss; Cell therapy; Steam cells.
How to Cite
References
Noman M, Bukhari SA, Tahir M, Ali S. A comprehensive review on inherited Sensorineural Hearing Loss and their syndromes. 2020;
Ciorba A, Bianchini C, Pelucchi S, Pastore A. The impact of hearing loss on the quality of life of elderly adults. Clin Interv Aging. 2012;159–63.
Vlajkovic SM, Thorne PR. Molecular mechanisms of sensorineural hearing loss and development of inner ear therapeutics. Vol. 22, International Journal of Molecular Sciences. MDPI; 2021. p. 5647.
Liu W, Wang X, Wang M, Wang H. Protection of spiral ganglion neurons and prevention of auditory neuropathy. Hear Loss Mech Prev Cure. 2019;93–107.
Firszt JB, Reeder RM, Skinner MW. Restoring hearing symmetry with two cochlear implants or one cochlear implant and a contralateral hearing aid. 2008;
Eshraghi AA, Jung HD, Mittal R. Recent advancements in gene and stem cell‐based treatment modalities: Potential implications in noise‐induced hearing loss. Anat Rec. 2020;303(3):516–26.
Jongkamonwiwat N, Zine A, N Rivolta M. Stem cell based therapy in the inner ear: appropriate donor cell types and routes for transplantation. Curr Drug Targets. 2010;11(7):888–97.
Martinez‐Monedero R, Yi E, Oshima K, Glowatzki E, Edge ASB. Differentiation of inner ear stem cells to functional sensory neurons. Dev Neurobiol. 2008;68(5):669–84.
Dufner-Almeida LG, Cruz DB da, Mingroni RC, Batissoco AC, Oiticica J, Salazar-Silva R. Stem-cell therapy for hearing loss: are we there yet? Braz J Otorhinolaryngol. 2019;85:520–9.
Roccio M. Directed differentiation and direct reprogramming: Applying stem cell technologies to hearing research. Stem Cells. 2021;39(4):375–88.
Matsumoto M, Nakagawa T, Kojima K, Sakamoto T, Fujiyama F, Ito J. Potential of embryonic stem cell‐derived neurons for synapse formation with auditory hair cells. J Neurosci Res. 2008;86(14):3075–85.
Hashino E, Fritsch MH. Embryonic stem cell-derived neurons for inner ear therapy. Embryonic Stem Cells-Recent Adv Pluripotent Stem Cell-Based Regen Med Tech. 2011;189–202.
Kim SY, Lee JE, Kang SH, Lee SM, Jeon J, Lee DR. The Protective Effects of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells in Noise-Induced Hearing Loss of Rats. Cells. 2022;11(21):3524.
Nakagawa T, Ito J. Cell therapy for inner ear diseases. Curr Pharm Des. 2005;11(9):1203–7.
Gunewardene N, Crombie D, Dottori M, Nayagam BA. Innervation of Cochlear Hair Cells by Human Induced Pluripotent Stem Cell‐Derived Neurons In Vitro. Stem Cells Int. 2016;2016(1):1781202.
Nishimura K, Nakagawa T, Ono K, Ogita H, Sakamoto T, Yamamoto N, et al. Transplantation of mouse induced pluripotent stem cells into the cochlea. Neuroreport. 2009;20(14):1250–4.
Taura A, Nakashima N, Ohnishi H, Nakagawa T, Funabiki K, Ito J, et al. Regenerative therapy for vestibular disorders using human induced pluripotent stem cells (iPSCs): neural differentiation of human iPSC-derived neural stem cells after in vitro transplantation into mouse vestibular epithelia. Acta Otolaryngol. 2016;136(10):999–1005.
Chen J, Hong F, Zhang C, Li L, Wang C, Shi H, et al. Differentiation and transplantation of human induced pluripotent stem cell-derived otic epithelial progenitors in mouse cochlea. Stem Cell Res Ther. 2018;9:1–15.
Kanzaki S, Toyoda M, Umezawa A, Ogawa K. Application of mesenchymal stem cell therapy and inner ear regeneration for hearing loss: a review. Int J Mol Sci. 2020;21(16):5764.
Kasagi H, Kuhara T, Okada H, Sueyoshi N, Kurihara H. Mesenchymal stem cell transplantation to the mouse cochlea as a treatment for childhood sensorineural hearing loss. Int J Pediatr Otorhinolaryngol. 2013;77(6):936–42.
Lee HS, Kim WJ, Gong JS, Park KH. Clinical safety and efficacy of autologous bone marrow-derived mesenchymal stem cell transplantation in sensorineural hearing loss patients. J Audiol Otol. 2018;22(2):105.
Maharajan N, Cho GW, Jang CH. Therapeutic application of mesenchymal stem cells for cochlear regeneration. In Vivo (Brooklyn). 2021;35(1):13–22.
Lang H, Xing Y, Brown LN, Samuvel DJ, Panganiban CH, Havens LT, et al. Neural stem/progenitor cell properties of glial cells in the adult mouse auditory nerve. Sci Rep. 2015;5(1):13383.
Hao F, Shan C, Zhang Y, Zhang Y, Jia Z. Exosomes derived from microRNA-21 overexpressing neural progenitor cells prevent hearing loss from ischemia-reperfusion injury in mice via inhibiting the inflammatory process in the cochlea. ACS Chem Neurosci. 2022;13(16):2464–72.
Hsu Y-C, Tsai C-L. Differentiation of inner ear cell types from human-induced pluripotent stem cells for the therapeutic application in sensorineural hearing loss. In: Recent Advances in iPSC-Derived Cell Types. Elsevier; 2021. p. 97–119.
Ronaghi M, Nasr M, Ealy M, Durruthy-Durruthy R, Waldhaus J, Diaz GH, et al. Inner ear hair cell-like cells from human embryonic stem cells. Stem Cells Dev. 2014;23(11):1275–84.
Fetoni AR, Lattanzi W, Eramo SLM, Barba M, Paciello F, Moriconi C, et al. Grafting and early expression of growth factors from adipose-derived stem cells transplanted into the cochlea, in a guinea pig model of acoustic trauma. Front Cell Neurosci. 2014;8:334.
Kamiya K, Fujinami Y, Hoya N, Okamoto Y, Kouike H, Komatsuzaki R, et al. Mesenchymal stem cell transplantation accelerates hearing recovery through the repair of injured cochlear fibrocytes. Am J Pathol. 2007;171(1):214–26.
Warnecke A, Harre J, Shew M, Mellott AJ, Majewski I, Durisin M, et al. Successful treatment of noise-induced hearing loss by mesenchymal stromal cells: an RNAseq analysis of protective/repair pathways. Front Cell Neurosci. 2021;15:656930.
Takeda H, Dondzillo A, Randall JA, Gubbels SP. Challenges in cell-based therapies for the treatment of hearing loss. Trends Neurosci. 2018;41(11):823–37.
Mittal R, Nguyen D, Patel AP, Debs LH, Mittal J, Yan D, et al. Recent advancements in the regeneration of auditory hair cells and hearing restoration. Front Mol Neurosci. 2017;10:236.
Kesser BW, Lalwani AK. Gene therapy and stem cell transplantation: strategies for hearing restoration. Gene Ther Cochlear Deaf. 2009;66:64–86.
Qiu Y, Qiu J. Stem cells: a new hope for hearing loss therapy. Hear Loss Mech Prev Cure. 2019;165–80.
Czajkowski A, Mounier A, Delacroix L, Malgrange B. Pluripotent stem cell-derived cochlear cells: a challenge in constant progress. Cell Mol Life Sci. 2019;76:627–35.
Fang Q, Wei Y, Zhang Y, Cao W, Yan L, Kong M, et al. Stem cells as potential therapeutics for hearing loss. Front Neurosci. 2023;17:1259889.
Samadi P, Saki S, Manoochehri H, Sheykhhasan M. Therapeutic applications of mesenchymal stem cells: a comprehensive review. Curr Stem Cell Res Ther. 2021;16(3):323–53.
Chorath K, Willis M, Morton-Gonzaba N, Moreira A. Mesenchymal stem cells for sensorineural hearing loss: a systematic review of preclinical studies. Mol Biol Rep. 2020;47(6):4723–36.
Nourbakhsh A, Colbert BM, Nisenbaum E, El-Amraoui A, Dykxhoorn DM, Koehler KR, et al. Stem cells and gene therapy in progressive hearing loss: the state of the art. J Assoc Res Otolaryngol. 2021;22:95–105.
Zine A, Messat Y, Fritzsch B. A human induced pluripotent stem cell-based modular platform to challenge sensorineural hearing loss. Stem Cells. 2021;39(6):697–706.
Sakamoto T, Nishimura K, Ohnishi H, Iki T. Pluripotent Stem Cells. Regen Med Inn Ear. 2014;287–303.
Durán-Alonso MB. Stem cell-based approaches: Possible route to hearing restoration? World J Stem Cells. 2020;12(6):422.
Okano T, Kelley MW. Stem cell therapy for the inner ear: recent advances and future directions. Trends Amplif. 2012;16(1):4–18.
Hao J, Li SK. Inner ear drug delivery: recent advances, challenges, and perspective. Eur J Pharm Sci. 2019;126:82–92.
Pauley S, Kopecky B, Beisel K, Soukup G, Fritzsch B. Stem cells and molecular strategies to restore hearing. Panminerva Med. 2008;50(1):41.
Atkinson PJ, Kim GS, Cheng AG. Direct cellular reprogramming and inner ear regeneration. Expert Opin Biol Ther. 2019;19(2):129–39.
Motaln H, Schichor C, Lah TT. Human mesenchymal stem cells and their use in cell‐based therapies. Cancer Interdiscip Int J Am Cancer Soc. 2010;116(11):2519–30.
Stojkovic M, Han D, Jeong M, Stojkovic P, Stankovic KM. Human induced pluripotent stem cells and CRISPR/Cas-mediated targeted genome editing: Platforms to tackle sensorineural hearing loss. Stem Cells. 2021;39(6):673–96.
Hong I-S. Enhancing stem cell-based therapeutic potential by combining various bioengineering technologies. Front Cell Dev Biol. 2022;10:901661.
Praetorius M, Vicario I, Schimmang > Thomas. Efficient transfer of embryonic stem cells into the cochlea via a non-invasive vestibular route. Acta Otolaryngol. 2008;128(7):720–3.
Vachheta DN, Shah YD, Athalye MN, Kakkad DK, Darji MJ. Treating Sensorineural Hearing Loss: Recent Advances in Inner Ear Drug Delivery. Drug Deliv Lett. 2023;13(3):167–85.
Gillespie LN, Richardson RT, Nayagam BA, Wise AK. Treating hearing disorders with cell and gene therapy. J Neural Eng. 2014;11(6):65001.
Arambula A, Arnoldner C, Warnecke A, Staecker H. The Augmented Cochlear Implant: a Convergence of Drugs and Cochlear Implantation for the Treatment of Hearing Loss. Curr Otorhinolaryngol Rep. 2022;10(4):349–56.
- Abstract Viewed: 68 times
- PDF Downloaded: 46 times